181 related articles for article (PubMed ID: 15514942)
21. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer.
Ishigaki K; Namba H; Nakashima M; Nakayama T; Mitsutake N; Hayashi T; Maeda S; Ichinose M; Kanematsu T; Yamashita S
J Clin Endocrinol Metab; 2002 Jul; 87(7):3433-40. PubMed ID: 12107263
[TBL] [Abstract][Full Text] [Related]
22. Krüppel-like factor 9 was down-regulated in esophageal squamous cell carcinoma and negatively regulated beta-catenin/TCF signaling.
Qiao F; Yao F; Chen L; Lu C; Ni Y; Fang W; Jin H
Mol Carcinog; 2016 Mar; 55(3):280-91. PubMed ID: 25641762
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
[TBL] [Abstract][Full Text] [Related]
24. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
[TBL] [Abstract][Full Text] [Related]
26. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
28. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers.
Miwa N; Furuse M; Tsukita S; Niikawa N; Nakamura Y; Furukawa Y
Oncol Res; 2001; 12(11-12):469-76. PubMed ID: 11939410
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation.
Mariadason JM; Bordonaro M; Aslam F; Shi L; Kuraguchi M; Velcich A; Augenlicht LH
Cancer Res; 2001 Apr; 61(8):3465-71. PubMed ID: 11309309
[TBL] [Abstract][Full Text] [Related]
30. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
Chen RH; McCormick F
Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
[TBL] [Abstract][Full Text] [Related]
31. Securin (hPTTG1) expression is regulated by beta-catenin/TCF in human colorectal carcinoma.
Hlubek F; Pfeiffer S; Budczies J; Spaderna S; Jung A; Kirchner T; Brabletz T
Br J Cancer; 2006 Jun; 94(11):1672-7. PubMed ID: 16705313
[TBL] [Abstract][Full Text] [Related]
32. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells.
Li Q; Dashwood RH
J Biol Chem; 2004 Oct; 279(44):45669-75. PubMed ID: 15331612
[TBL] [Abstract][Full Text] [Related]
33. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
34. Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
Dihlmann S; Kloor M; Fallsehr C; von Knebel Doeberitz M
Carcinogenesis; 2005 Sep; 26(9):1503-12. PubMed ID: 15888491
[TBL] [Abstract][Full Text] [Related]
35. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM
Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259
[TBL] [Abstract][Full Text] [Related]
36. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
[TBL] [Abstract][Full Text] [Related]
37. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
[TBL] [Abstract][Full Text] [Related]
38. Synergistic activation of the murine gastrin promoter by oncogenic Ras and beta-catenin involves SMAD recruitment.
Chakladar A; Dubeykovskiy A; Wojtukiewicz LJ; Pratap J; Lei S; Wang TC
Biochem Biophys Res Commun; 2005 Oct; 336(1):190-6. PubMed ID: 16139800
[TBL] [Abstract][Full Text] [Related]
39. Identification of Tcf-4 as a transcriptional target of p53 signalling.
Rother K; Johne C; Spiesbach K; Haugwitz U; Tschöp K; Wasner M; Klein-Hitpass L; Möröy T; Mössner J; Engeland K
Oncogene; 2004 Apr; 23(19):3376-84. PubMed ID: 14990988
[TBL] [Abstract][Full Text] [Related]
40. Reconstructed beta-catenin/TCF4 signaling in yeast applicable to functional evaluation of APC mutations.
Yamada H; Furuuchi K; Aoyama T; Kataoka A; Hamada J; Tada M; Okushiba S; Kondo S; Moriuchi T; Katoh H
Am J Pathol; 2003 Dec; 163(6):2201-9. PubMed ID: 14633595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]